Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 458

1.

Pooled Analysis of the Associations between Body Mass Index, Total Cholesterol, and Liver Cancer-related Mortality in Japan

Ukawa S, Tamakoshi A, Murakami Y, Kiyohara Y, Yamada M, Nagai M, Satoh A, Miura K, Ueshima H, Okamura T, EPOCH-JAPAN Research Group.

Asian Pac J Cancer Prev. 2018 Aug 24;19(8):2089-2095.

2.

Prevalence of and risk factors for cerebral microbleeds in a general Japanese elderly community.

Yubi T, Hata J, Ohara T, Mukai N, Hirakawa Y, Yoshida D, Gotoh S, Hirabayashi N, Furuta Y, Ago T, Kitazono T, Kiyohara Y, Ninomiya T.

Neurol Clin Pract. 2018 Jun;8(3):223-231. doi: 10.1212/CPJ.0000000000000464.

PMID:
30105162
3.

Prevalence and Risk Factors for Polypoidal Choroidal Vasculopathy in a General Japanese Population: The Hisayama Study.

Fujiwara K, Yasuda M, Hata J, Oshima Y, Hashimoto S, Yoshitomi T, Kiyohara Y, Ishibashi T, Ninomiya T, Sonoda KH.

Semin Ophthalmol. 2018;33(6):813-819. doi: 10.1080/08820538.2018.1506483. Epub 2018 Aug 7.

PMID:
30084710
4.

Associations of Overweight, Obesity, and Underweight With High Serum Total Cholesterol Level Over 30 Years Among the Japanese Elderly: NIPPON DATA 80, 90, and 2010.

Shibata Y, Ojima T, Nakamura M, Kuwabara K, Miyagawa N, Saito Y, Nakamura Y, Kiyohara Y, Nakagawa H, Fujiyoshi A, Kadota A, Ohkubo T, Okamura T, Ueshima H, Okayama A, Miura K.

J Epidemiol. 2018 Jul 21. doi: 10.2188/jea.JE20170229. [Epub ahead of print]

5.

Serum 1,25-Dihydroxyvitamin D Level Is Inappropriate for Use in Prospective Studies of Cancer Incidence - Reply.

Umehara K, Mukai N, Kitazono T, Hoka S, Kiyohara Y, Ninomiya T.

Circ J. 2018 Jul 25;82(8):2216. doi: 10.1253/circj.CJ-17-0909. Epub 2018 Jul 11. No abstract available.

6.

Secular trends in the incidence, risk factors, and prognosis of transient ischemic attack in Japan: The Hisayama Study.

Furuta Y, Hata J, Mukai N, Hirakawa Y, Ago T, Kitazono T, Kiyohara Y, Ninomiya T.

Atherosclerosis. 2018 Jun;273:84-90. doi: 10.1016/j.atherosclerosis.2018.04.010. Epub 2018 Apr 12.

PMID:
29702429
7.

Safety and efficacy of nivolumab in Japanese patients with malignant melanoma: An interim analysis of a postmarketing surveillance.

Kiyohara Y, Uhara H, Ito Y, Matsumoto N, Tsuchida T, Yamazaki N.

J Dermatol. 2018 Apr;45(4):408-415. doi: 10.1111/1346-8138.14227. Epub 2018 Feb 20.

PMID:
29464755
8.

Phase 1/2 study assessing the safety and efficacy of dabrafenib and trametinib combination therapy in Japanese patients with BRAF V600 mutation-positive advanced cutaneous melanoma.

Yamazaki N, Tsutsumida A, Takahashi A, Namikawa K, Yoshikawa S, Fujiwara Y, Kondo S, Mukaiyama A, Zhang F, Kiyohara Y.

J Dermatol. 2018 Apr;45(4):397-407. doi: 10.1111/1346-8138.14210. Epub 2018 Feb 5.

9.

Albuminuria Increases the Risks for Both Alzheimer Disease and Vascular Dementia in Community-Dwelling Japanese Elderly: The Hisayama Study.

Takae K, Hata J, Ohara T, Yoshida D, Shibata M, Mukai N, Hirakawa Y, Kishimoto H, Tsuruya K, Kitazono T, Kiyohara Y, Ninomiya T.

J Am Heart Assoc. 2018 Jan 20;7(2). pii: e006693. doi: 10.1161/JAHA.117.006693.

10.

Immune response-associated gene profiling in Japanese melanoma patients using multi-omics analysis.

Akiyama Y, Kiyohara Y, Yoshikawa S, Otsuka M, Kondou R, Nonomura C, Miyata H, Iizuka A, Ashizawa T, Ohshima K, Urakami K, Nagashima T, Kusuhara M, Sugino T, Yamaguchi K.

Oncol Rep. 2018 Mar;39(3):1125-1131. doi: 10.3892/or.2017.6173. Epub 2017 Dec 21.

PMID:
29286146
11.

Comparative profiling of cortical gene expression in Alzheimer's disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation.

Castillo E, Leon J, Mazzei G, Abolhassani N, Haruyama N, Saito T, Saido T, Hokama M, Iwaki T, Ohara T, Ninomiya T, Kiyohara Y, Sakumi K, LaFerla FM, Nakabeppu Y.

Sci Rep. 2017 Dec 19;7(1):17762. doi: 10.1038/s41598-017-17999-3.

12.

Nail apparatus melanoma in a Japanese population: a comparative study of surgical procedures and prognoses in a large series of 151 cases.

Ogata D, Uhara H, Tsutsumida A, Yamazaki N, Mochida K, Amano M, Yoshikawa S, Kiyohara Y, Tsuchida T.

Eur J Dermatol. 2017 Dec 1;27(6):620-626. doi: 10.1684/ejd.2017.3133.

PMID:
29165298
13.

Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON).

Namikawa K, Tsutsumida A, Mizutani T, Shibata T, Takenouchi T, Yoshikawa S, Kiyohara Y, Uchi H, Furue M, Ogata D, Tsuchida T, Yamazaki N.

Jpn J Clin Oncol. 2017 Jul 1;47(7):664-667. doi: 10.1093/jjco/hyx063.

14.

Development and validation of a risk assessment tool for gastric cancer in a general Japanese population.

Iida M, Ikeda F, Hata J, Hirakawa Y, Ohara T, Mukai N, Yoshida D, Yonemoto K, Esaki M, Kitazono T, Kiyohara Y, Ninomiya T.

Gastric Cancer. 2018 May;21(3):383-390. doi: 10.1007/s10120-017-0768-8. Epub 2017 Oct 17.

PMID:
29043529
15.

Safety, tolerability, and pharmacokinetic profile of dabrafenib in Japanese patients with BRAF V600 mutation-positive solid tumors: a phase 1 study.

Fujiwara Y, Yamazaki N, Kiyohara Y, Yoshikawa S, Yamamoto N, Tsutsumida A, Nokihara H, Namikawa K, Mukaiyama A, Zhang F, Tamura T.

Invest New Drugs. 2018 Apr;36(2):259-268. doi: 10.1007/s10637-017-0502-8. Epub 2017 Sep 7.

PMID:
28879519
16.

White-coat and masked hypertension are associated with albuminuria in a general population: the Hisayama Study.

Hata J, Fukuhara M, Sakata S, Arima H, Hirakawa Y, Yonemoto K, Mukai N, Kitazono T, Kiyohara Y, Ninomiya T.

Hypertens Res. 2017 Nov;40(11):937-943. doi: 10.1038/hr.2017.74. Epub 2017 Sep 7.

PMID:
28878300
17.

Day-to-Day Blood Pressure Variability and Risk of Dementia in a General Japanese Elderly Population: The Hisayama Study.

Oishi E, Ohara T, Sakata S, Fukuhara M, Hata J, Yoshida D, Shibata M, Ohtsubo T, Kitazono T, Kiyohara Y, Ninomiya T.

Circulation. 2017 Aug 8;136(6):516-525. doi: 10.1161/CIRCULATIONAHA.116.025667.

18.

The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell line.

Akiyama Y, Nonomura C, Ashizawa T, Iizuka A, Kondou R, Miyata H, Sugino T, Mitsuya K, Hayashi N, Nakasu Y, Asai A, Ito M, Kiyohara Y, Yamaguchi K.

Immunol Lett. 2017 Oct;190:20-25. doi: 10.1016/j.imlet.2017.07.005. Epub 2017 Jul 15.

PMID:
28716484
19.

Characteristics of adverse drug reactions in a vemurafenib early post-marketing phase vigilance study in Japan.

Uhara H, Kiyohara Y, Tsuda A, Takata M, Yamazaki N.

Clin Transl Oncol. 2018 Feb;20(2):169-175. doi: 10.1007/s12094-017-1706-2. Epub 2017 Jul 3.

20.

The ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cancer death in a Japanese community: The Hisayama Study.

Nagata M, Hata J, Hirakawa Y, Mukai N, Yoshida D, Ohara T, Kishimoto H, Kawano H, Kitazono T, Kiyohara Y, Ninomiya T.

J Epidemiol. 2017 Dec;27(12):578-583. doi: 10.1016/j.je.2017.01.004. Epub 2017 Jun 29.

Supplemental Content

Loading ...
Support Center